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Prodigious substrate specificity of AAC(6’)-APH(2”), an 
aminoglycoside antibiotic resistance determinant in 
enterococci and staphylococci 
Denis M Daiglel, Donald W Hughes* and Gerard D Wright’ 
Background: High-level gentamicin resistance in enterococci and 
staphylococci is conferred by AAC(G’)-APH(2”), an enzyme with 6’-N-acetyl- 
transferase and 2”-O-phosphotransferase activities. The presence of this 
enzyme in pathogenic gram-positive bacteria prevents the successful use of 
gentamicin C and most other aminoglycosides as therapeutic agents. 
Results: In an effort to understand the mechanism of aminoglycoside 
modification, we expressed AAC(G’)-APH(2”) in Bacillus subtdis. The purified 
enzyme is monomeric with a molecular mass of 57 kDa and displays both the 
expected aminoglycoside N-acetyltransferase and 0-phosphotransferase 
activities. Structure-function analysis with various aminoglycosides substrates 
reveals an enzyme with broad specificity in both enzymatic activities, accounting 
for AAC(6’)-APH(2”)‘s dramatic negative impact on clinical aminoglycoside 
therapy. Both lividomycin A and paromomycin, aminoglycosides lacking a 
6’-amino group, were acetylated by AAC(G’)-APH(2”). The infrared spectrum of 
the product of paromomycin acetylation yielded a signal consistent with 
0-acetylation. Mass spectral and nuclear magnetic resonance analysis of the 
products of neomycin phosphorylation indicated that phosphoryl transfer 
occurred primarily at the 3’-OH of the 6-aminohexose ring A, and that some 
diphosphorylated material was also present with phosphates at the 3’-OH and 
the 3”‘-OH of ring D, both unprecedented observations for this enzyme. 
Furthermore, the phosphorylation site of lividomycin A was determined to be the 
5”-OH of the pentose ring C. 
Conclusions: The bifunctional AAC(G’)-APH(2”) has the capacity to inactivate 
virtually all clinically important aminoglycosides through N- and 0-acetylation 
and phosphorylation of hydroxyl groups. The extremely broad substrate 
specificity of this enzyme will impact on future development of aminoglycosides 
and presents a significant challenge for antibiotic design. 
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Introduction 
Aminoglycoside antibiotics are important bactericidal agents 
used for the treatment of many bacterial infections [l]. The 
aminoglycosides are generally comprised of a central Z- 
deoxystreptamine aminocyclitol ring to which amino sugars 
are linked either at positions 4 and 6, such as gentamicin 
and kanamycin, or at position 4 and 5, such as neomycin and 
lividomycin (Figure 1). These cationic molecules exert their 
antibacterial effects by binding to the 30s ribosomal subunit 
and thereby disrupting bacterial translation [Z]. The bacteri- 
cidal action and broad antibacterial specificity of these drugs 
has rendered them highly useful for the treatment of noso- 
comial (hospital acquired) infections. 
Bacterial resistance to aminoglycosides is a growing prob- 
lem [3-.5]. The primary route of clinical resistance is the 
acquisition of genes encoding enzymes that covalently 
modify the drugs by 0-phosphorylation, N-acetylation and 
0-adenylation [6,7]. The wide-spread dissemination of 
bacteria harboring these resistance genes in healthcare 
institutions has compromised the usefulness of aminogly- 
cosides, many of which are consequently no longer clini- 
cally effective. 
The gentamicin C complex is comprised of three closely 
related aminoglycoside components, Cl, Cla and C2 
(Figure i), and is extensively used in the clinic [l]. In 
particular, it is required for use in combination with a 
penicillin to achieve a synergistic killing effect for the 
treatment of serious enterococcal infections [8]. Entero- 
cocci can harbor several distinct aminoglycoside-modify- 
ing enzymes [9], but one protein with two enzymatic 
activities, 6’-L\r-acetyltransferdse and Z”-O-phosphotrans- 
ferase (AAC(6’)-APH(Z”)), has been implicated in high- 
level gentamicin C resistance (minimal inhibitory concen- 
trations [MICs] > 2,000 g/ml) [lo]. The gene that encodes 
IO0 Chemistry & Biology 1999, Vof 6 No 2 
Figure t 
“wNL2 - 
0 ’ 
Gentamicin 
Cl ,R,=R,=CH, 
Cl a,R,=R,=H 
C2,R,=CH,,RPH 
OH 
OH 
Liiidomycin A 
YN p-+-Cl 
HO 
O-7 
NH2 
i-&N OH 
Neomycin B Fortimicin A 
Chsmistw & Eidoav 
Structures of representative aminoglycos~de 
antibiotics. 
this bifunctional enzyme is generally found on transposable 
elements (e.g. Tn5281 in Ent~r~~~~c~s&~~& [1 I]) and these 
elements are frequently carried on R plasmids but can also 
be detected integrated into the chromosome [t&13]. The 
mobile nature of this gene has permitted intergenus trans- 
fex and the a~,$6’)-@&2“j gene can be found in staphylo- 
cocci as well, where it also results in high-level gentamicin 
C resistance, (e.g. Tn4003 in S~~~~~?lococctls LIPLYZZJS 1141 and 
Tn403l in ~~~~~~~~~0~6~s ~p~~~~s [IS]). 
The compIete ~~~6~~-~~~~~~~~ gene has been cloned and 
sequenced from isolates of E.&~&~& [16] and S. LLWW-S f17]. 
The protein is predicted to have a molecular mass of 54,993 
Da, in good agreement with the experimentally determined 
sizes of errzymes previously purified from S. ng?-eas and 
‘5’. epidemidis its]. Construction of S-truncated u&6’)- 
n$&2”) genes has revealed that the AAC activity resides in 
the amino-terminal portion of the enzyme and that the 
APH acrivity is Iocaiized to the carboxy terminus [I6]. This 
is in agreement with amino-acid alignments thar demon- 
strate sequence homology to AAC(6’) enzymes in the 
amino terminus and to APH enzymes in the carboxyi ter- 
minus; these observations have led to the suggesGon that 
the bifu~ctionai enzyme has arisen from a gene-fusion 
event. [6,16]. The kinetic mechanism of both the AAC and 
APH activities have been determined using enzyme par- 
tially purified from S. GUP%W 1191, and, recently, the enzyme 
has been expressed and purified from Eschetichia cdi and 
the predicted regiospecificity of both phosphoryl (2”-OH) 
and acetyl (6’~NH,) transfer confirmed using kanamycin 
1201. Moreover, bifunctionalization (6’-acetyl and Z”-phos- 
phoryl) of kanar~~cin was also detected in this system, 
although it is not known if this results in higher MICs. The 
regiospeci~ci~ of phospho~l transfer to the ne~~rn~cin ctass 
of ~minoglycosid~s that have pentoses in the C ring 
(Figure 1) has not been determined. We report overexpres- 
sion of the .~~(~‘)-AFT bifuncti(~nal enzyme from 
~~~~~~s s&&s along with &haracteri~ation of substrate 
specificity and regiospecificity of phosphoryl transfer. 
Results 
Exprrusion of AAC@Y)-APH(2”) in B. subtilis 
When we expressed AAC(6’)-APH(2”) in E, COG using 
several gene constructs, we consistently found a mixture 
of products that consisted of the intact 57 kDa enzyme 
and a 34 kDa protein with only APEI activity, which 
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Table 1 
Purification of AAC(6’)-APH(2”) from a 10 I culture of 6. subtilis lA762/pBF-14. 
Step Protein (mg) 
Cell lysate 1950 
G Sepharose 629 
Sephadex Gl 00 255 
Gentamicin-agarose 71.8 
Activity (U) 
APH* - 
AAC 47.3 
APH 22.4 
AAC 27.0 
APH 26.3 
AK 24.8 
APH 15.8 
AAC 13.0 
Specific activity (Ulmg) 
APH - 
AN2 0.024 
APH 0.036 
AAC 0.044 
APH 0.103 
AAC 0.098 
APH 0.22 
AAC 0.181 
Recovery (Vo) 
APH - 
AAC 100 
APH 100 
AAC 59 
APH 100 
AAC 63 
APH 70 
AAC 28 
Purification (n-fold) 
APH - 
AAC 0 
APH - 
AAC 1.9 
APH 4.3 
Am 4.0 
APH 9.2 
AAC 7.5 
1 U = 1 pmolelmin. *High levels of nonspecific ATPase activity 
precluded accurate detection of APH activity. APH activity was 
monitored by pyruvate kinasellactate dehydrogenase coupled assay 
was not the result of protease activity but rather appears 
to be due to an alternate translation initiation event (D.M.D. 
and G.D.W., unpublished observations). The poor yields 
of intact AAC(6’)-APH(Z”) when expressed in I?. co/i led 
us to explore expression in B. s&t&s. The gene encoding 
AAC(6’)-APH(2”) was amplified from pSF815A [16] and 
cloned into plasmid pRB374 [Zl] to give plasmid pBF-14, 
which places the bifunctional gene under transcriptional 
control of the constitutive B. szlbti/is neg1Z promoter. This 
construct gave excellent expression of AAC(6’)-APH(2”) in 
B. szcbtilis lA752 and a three-step purification provided intact 
enzyme with a yield of greater than 70 mg per 10 1 of cell 
culture (Table 1, Figure 2). 
Substrate specificity of MC@‘) activity 
As expected, the purified enzyme had a very broad sub- 
strate range (Tables 2 and 3). Aminoglycosides with a free 
Figure 2 
Purification of AAC(6’)-APH(2”) from B. subfilis lA752/pBF-14. 
Sodium dodecyl sulfate- polyacrylamide gel electrophoresis 
(SDS-PAGE) on an 11% gel of the progress of the purification of 
AAC(G’)-APH(2”) was stained with Coomassie Blue R-250. Lysis and 
purification were performed according to the procedure in the 
Materials and methods section. Lane 1, molecular mass markers; 
lane 2, cell lysate (Sl); lane 3, Cl Sepharose; lane 4, Sephadex Gl 00; 
lane 5, Gentamicin C-agarose; lane 6, molecular mass markers. 
and therefore the overall increase in specific activity was low due to 
contaminating ATPases that prevented accurate assay in crude 
fractions. 
6’-amino group were all acetylated with comparable effi- 
ciency (lOa-10” M-l s-i) as was fortimicin, an unusual 
property of the AAC(6’) class of enzymes. These values 
are similar to other aminoglycoside acetyltransferases 
such AAC(6’)-Ii from E. fae&m [ZZ]. Unexpectedly, the 
h’-hydroxy aminoglycoside antibiotics lividomycin A and 
paromomycin were not inhibitors of the 6’-N-acetylase 
activity as they have been shown to be for AAC(6’)-Ii [Z]. 
Instead, they were substrates for the acetyltransferase 
with a K, comparable to other aminoglycosides, but with a 
diminished k,,, (Table 2). This suggested either transfer 
to an alternate amino group on the molecule or O-acetyl- 
transfer to position 6’. Enzymatically acetylated paromo- 
mycin and lividomycin A were highly susceptible to mild 
base hydrolysis supporting the 0-acetyltransfer hypothesis 
(Figure 3a). Purification of acetyl-paromomycin and subse- 
quent analysis by infrared spectrometry identified a promi- 
nent signal at 1719 cm-i, consistent with formation of the 
h’-acetyl ester (Figure 3b). 
Substrate specificity and regiospecificity of APH(2”) activity 
Unlike the AAC(6’) activity of the bifunctional enzyme, 
there was more deviation in the specificity of the APH 
activity with K, varying from Z-ZOO @I and k,,,/K, values 
from 103-10” Iv-i s-i (Table 3). These values are similar to 
those found with the broad specificity aminoglycoside 
kinase APH(3’)-IIIa [23] but are lower than those found 
for other APH(3’)s in which k,,,/K, approach diffusion- 
controlled levels [24]. The broad scope of aminoglycosides 
that are substrates for the APH(Z”) surpasses the APH(3’)s 
and other aminoglycoside kinases, however. The regio- 
specificity of phosphor-y1 transfer to kanamycin A has been 
determined using nuclear magnetic resonance (NMR) 
methods to be at the 2”-OH in ring C [ZO]. The regio- 
specificity of Pi transfer for the 4,5-disubstituted class of 
aminoglycosides such as neomycin, in which ring C is a 
pentose, was unknown, however. Large-scale inactivations 
of neomycin C revealed two products that were identified 
as mono-phosphoryl neomycin (m/z 695.4) and diphos- 
phoryl neomycin (m/z 775.3) using electrospray mass 
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Table 2 
Kinetic parameters for AAC(6’) activity. 
Substrate* K, @M) kc,, L-‘1 K, (PM) k,,,/K, (M-‘s-‘) 
Kanamycin A 1.4 k 0.5 0.31 f 0.05 50.2 f 22.3 2.21 x 105 
Kanamycin 6 7.5 * 5.0 1.3 f 0.5 23.1 + 15.1 1.7x 105 
Tobramycin 2.3 + 0.9 0.68 f 0.1 50.0 + 20.1 3.0 x 105 
Dibekacin 2.4 f 1.8 1.5 * 0.4 43.8 rt 27.3 6.2~10~ 
Amikacin 20.9 rL 5.3 2.1 1 + 0.35 23.7 f 7.8 1.01 x 105 
Gentamicin C+ 4.6 + 1.5 0.85 + 0.15 76.6 f 39.7 1.85 x 1 O5 
Gentamicin B 1 .l * 0.2 0.3 5 0.01 2.73 x 105 
lsepamicin 18.7 f 9.0 1.66 k 0.50 88.3 IL 52.7 8.87 x 1 O4 
Netilmicin 3.2 + 0.5 0.87 2~ 0.04 2.72x IO5 
Sisomicin 6.5k2.1 2.92 f 0.31 4.5 x 105 
Neomycin B 4.2 rk 0.8 1.53 f 0.09 3.64 x 105 
Ribostamicin 6.1 rt 2.5 2.06 f 0.47 54.7k31.4 3.38 x 1 O5 
Butirosin A 25.8 f 2.7 1.27 IO.06 4.92 x 104 
Neamine 8.4 I? 5.4 3.0 i 1.3 15.0 f 9.4 3.6~10~ 
Fortimicin 2.2 * 0.4 0.19f0.01 8.64 x 1 O4 
Lividomycin A 10.1 + 2.8 0.020 2 0.001 2.0 x 103 
Paromomycin 17.5 f 5.0 0.032 IL 0.02 1.8x lo3 
Acetyl CoA* 5.9 Ylc 1.4 0.73 + 0.04 1.24 x 1 O5 
‘Acetyl CoA concentration was held at 0.1 mM for aminoglycoside assays. +Gentamicin C is a complex of gentamicin Cl, Cl a and C2. 
*Nonvarying substrate was kanamycin A (0.1 mM). 
spectrometry. ‘H, 13C and 31P-NMR spectra of product 
neomycin monophosphate were consistent with phospho- 
rylation on the 3’OH of ring A as we have shown previ- 
ously for APH(3’)-IIIa [ZS]. 
In order to determine the sites of phosphorylation in 
neomycin bisphosphate a combination of one- and two- 
dimensional NMR techniques were used. The ‘H chemi- 
cal shifts and coupling constants are reported in Tables 4 
Table 3 
and 5, whereas the 31P NMR data are shown in Table 6. 
The NVMR data for neomycin are also included in Tables 1 
and 2 for comparison. The analysis began by recording the 
‘H and 31P NMR spectra. When the lH NMR spectrum 
(Figure 4) was examined the majority of signals appeared 
between 2.90 and 4.40 ppm. There were also two groups 
of resolved signals. The first group was located in the 
5.20-5.80 ppm region and consisted of three doublets 
arising from the anomeric protons. The other group of 
Kinetic parameters for APH(2”) activity. 
Substrate* K, (PM) 
Kanamycin A 7.0 5 0.9 
Kanamycin B 9.3 f 2.2 
Tobramycin 4.8 + 1 .l 
Dibekacin 3.6 f 0.8 
Amikacin 158+33 
Gentamicin Ct 3.4 f 0.5 
Gentamicin B 38.9 + 8.5 
lsepamicin 197 + 44.0 
Netilmicin 36.4 k 5.7 
Sisomicin 12.2 ?I 1 .l 
Neomycin B 1.9 f 0.2 
Paromomycin 3.4 f 1.5 
Lividomycin A 32.9 + 8.1 
Ribostamycin 2.OkO.8 
Butirosin A 1 1.6 f 1.4 
Neamine 9.6k3.1 
ATP 24.1 f 6.1 
k, (s-‘1 
0.41 * 0.02 
1.07+0.16 
0.33 * 0.02 
0.34 k 0.02 
0.16 + 0.01 
0.23 f 0.01 
0.65 f 0.09 
0.59 k 0.04 
0.21 + 0.01 
0.4 f 0.01 
0.19 * 0.01 
0.49 + 0.1 
0.22 f 0.02 
0.25 f 0.04 
0.43 * 0.09 
0.17f0.01 
0.17Ifro.02 
K, (PM) 
65.4 IL 19.6 
173+49 
77.5 f 36.1 
176+108 
k,,JK, (M-‘s-‘) 
5.84 x 1 O4 
1.15x 105 
6.9x lo4 
9.4x 104 
1.0x 103 
6.8x 104 
1.67x lo4 
3.00 x 103 
5.77 x 103 
3.28 x 1 O4 
1 .o x 105 
1.44 x 105 
6.7 x 1 O3 
3.71 x 105 
3.71 x 104 
1.8~10~ 
7.1 x 103 
‘ATP concentration was held at 1 mM for aminoglycoside assays. +Gentamicin C is a complex of gentamicin Cl, Cl a and C2. *Nonvarying 
substrate was kanamycin A (0.1 mM). 
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Figure 3 Table 4 
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Evidence for 0-acetylation of paromomycin and lividomycin. 
(a) Sensitivity of [14C]-acetylated aminoglycosides to alkaline 
treatment. The amount of label remaining on the enzymatically 
acetylated aminoglycosides was determined by use of the 
phosphocellulose-binding assay as described in the Materials and 
methods section. 0 acetyl-kanamycin A; 0 acetyl-lividomycin A; 
V acetyl-paromomycin. (b) Infrared spectrum of purified acetyl- 
paromomycin. 
peaks appeared in the low frequency end of the spectrum 
at 2.090 and 1.411 ppm. These multiplets were assigned 
to the C-Z equatorial and axial methylene protons, respec- 
tively, on the aminocyclitol ring (ring B). The differentia- 
tion of the aminocyclitol methylene protons was based on 
the magnitude of the vicinal 3-bond coupling constants 
and the general trend of lower frequency chemical shifts 
for axial protons in cyclohexanes. 
Two signals were observed in the 31P spectrum at 4.407 
and 3.482 ppm. Each phosphorus signal underwent selec- 
tive irradiation and the “‘P-decoupled ‘H KMR spectrum 
was acquired. Irradiation of the phosphorus at 3.482 ppm 
resulted in the doublet of triplets at 4.303 ppm in the ‘H 
spectrum to collapse into a triplet. Similarly, when the 
‘H Chemical shifts of neomycin (1) and neomycin 
bisphosphate (2) in D,O. 
Chemical shift (ppm) 
Proton 1 2 
Ring A 
1 5.824 5.773 
2 3.242 3.289 
3 3.831 4.226 
4 3.309 3.463 
5 3.873 3.961 
6 3.318 3.280 
6’ 3.089 3.130 
Ring B 
1 3.149 3.080 
2e 2.188 2.090 
2a 1.636 1.411 
3 3.149 3.000 
4 3.76* 3.538 
5 3.76* 3.723 
6 3.546 3.462 
Ring C 
1 5.268 5.277 
2 4.288 4.252 
3 4.379 4.354 
4 4.080 4.073 
5 3.772 3.812 
5’ 3.598 3.630 
Ring D 
1 5.136 5.211 
2 3.421 3.603 
3 4.096 4.303 
4 3.678 3.825 
5 4.180 4.243 
6 3.274 3.291 
6’ 3.221 3.243 
‘Estimated chemical shifts owing to second-order effects resulting 
from signal overlap of ring B protons 4 and 5. 
4.407 ppm phosphorus signal was decoupled the proton 
multiplet at 4.226 ppm was reduced to a doublet of dou- 
blets. These spin-decoupling experiments identified the 
protons that were adjacent to the phosphate groups by 
removing the 3-bond 1H-31P coupling (Table 6). The next 
step was to assign these protons to specific positions in the 
neomycin structure. 
The assignment of the main group of multiplets between 
2.90 and 4.40 ppm initially involved following the correla- 
tions between spin-coupled protons in the COSY spec- 
trum starting from the anomeric protons. Only the protons 
from the ribose ring C were sufficiently resolved to allow a 
complete assignment from the COSY spectrum (Table 4). 
The sequence of correlations in the COSY spectrum start- 
ing from the 5.277 ppm anomeric proton revealed a six 
proton spin system that could only arise from the ribose 
ring. The critical outcome of this analysis was that the 
protons affected by the “‘P-decoupling experiments were 
not from ring C. Only a partial assignment of the protons 
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Table 5 Table 6 
IH-IH Coupling constants for neomycin (1) and neomycin 31P Chemical shifts and 31P-lH coupling constants of neomycin 
bisphosphate (2) in D,O. bisphosphate (2) in D,O. 
Coupling constant (Hz) 
Proton 1 2 
- 
3J 
Ring A 
172 3.9 3.9 
23 10.8 10.0 
3,4 9.2 8.8 
435 10.2 9.8 
576 3.3 3.8 
5,6’ 7.5 6.8 
Ring B 
1.2e 4.2 4.2 
1,2a 12.5 12.4 
176 10.2’ 10.4 
3,2e 4.2 4.1 
3,2a 12.5 12.2 
3,4 10.2’ 9.4 
475 * 9.8 
576 * 9.2 
Ring C 
172 2.2 2.4 
23 4.8 5.0 
3,4 6.9 6.9 
4,5 3.0 2.9 
4,5’ 5.1 4.9 
Ring D 
12 1.8 1.8 
2,3 3.2 3.2 
384 3.2 3.2 
4,5 1.5 1.5 
516 6.8 6.8 
5,6 3.9 4.3 
2J 
Ring A 
6,6’ -13.5 -13.5 
Ring B 
2e,2a -12.5 -12.4 
Ring C 
5,5’ -12.4 -12.4 
Ring D 
6,6’ -13.7 -13.6 
4J 
Ring D 
2,4 1.2 1.5 
*Coupling constants were estimated or not measured owing to 
second order effects as a result of the overlapped of the ring B 
protons 4 and 5. 
from carbohydrate rings A and D could be determined 
from the COSY spectrum because signal overlap made it 
difficult to unambiguously follow the connectivity between 
adjacent protons on these rings. 
The aminocyclitol protons were readily located in the 
COSY spectrum by following the connectivity pathway 
starting from the C-Z methylene protons. The assignment 
of the aminocyclitol protons remained uncertain, however, 
because of the nearly identical multiplicity and chemical 
Phosphorous 
Chemical Coupling 
shift (ppm) constant (Hz) 
Ring A 
3-P 
Ring-D 
3-P 
4.407 
3.482 
3JPH 
H-$P 
H-3,P 
7.1 
9.6 
shifts of the protons on carbons 1 and 3 of the B ring. As the 
phosphorus-coupled protons were not part of the amino- 
cyclitol spin system the analysis to this point indicated 
that phosphorylation must have occurred only in the A and 
D pyranose rings. 
The differentiation of the pyranose ring A and D protons 
relied on the detection of a nuclear Overhauser enhance- 
ment (NOE) between the anomeric protons and the protons 
on the ether-linked carbons in the neighbouring rings. A 
two-dimensional NOE experiment was performed using 
the transverse-ROESY pulse sequence [26]. In the ROESY 
spectrum the anomeric proton at 5.773 ppm displayed a 
cross-peak with the B ring proton at 3.538 ppm. This 
result confirmed that the 5.773 ppm doublet was the ring 
A anomeric proton, whereas the 3.538 ppm signal was the 
aminocyclitol C-4 proton. Establishing the assignment of 
the ring B H-4 proton allowed the chemical shifts of the 
remaining B ring protons to be assigned. 
The anomeric proton at 5.211 ppm displayed a strong 
ROESY cross-peak with the ribose ring C H-Z and H-3 
protons at 4.252 and 4.353 ppm, respectively. Thus the 
signal at 5.211 ppm was from the ring D anomeric proton. 
A reexamination of the COSY data resulted in the assign- 
ment of the ring D H-Z, H-3 and H-4 protons (Table 4). 
The identification of the phosphorus-coupled proton at 
4.303 ppm as the D ring H-3 confirmed one of the sites of 
phosphorylation as the hydroxyl group on position 3 of 
neomycin ring D (position 3”‘). 
In order to locate the other site of phosphorylation and 
resolve a number of overlapped ‘H signals the selective 
one-dimensional TOCSY pulse sequence was used [27,28]. 
When this pulse sequence was used to selectively excite 
the A ring anomeric proton, a *H spectrum was produced 
that contained all the A ring protons and therefore allowed 
the assignment of their chemical shifts (Table 4). The 
only signals that remained overlapped were the A ring 
H-2 and H-6 protons. These signals could be resolved by 
repeating the selective TOCSY experiment by irradiating 
either the H-l or H-5 protons and using a shorter spin 
lock time to limit the extent of coherence transfer through 
the spin system. The most significant result of the selective 
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Figure 4 
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TOCSY experiments was that the phosphorus-coupled iH 
at 4.226 ppm was found to be part of the A ring spin system 
and could be assigned to position 3 of ring A, which is posi- 
tion 3’ in the aminoglycoside literature. A similar series of 
selective TOCSY experiments were performed in order to 
complete the chemical shift assignments of the D ring C-S 
and C-6 protons (Table 4). 
The unexpected identification of the sites of phosphory- 
lation of neomycin as position 3’ and 3”’ prompted us to 
examine phosphorylation of the 3’-deoxy aminoglycoside 
lividomycin A. NMR analysis of the product of AAC(6’)- 
APH(2”) catalyzed phosphorylation of this compound 
revealed phosphorylation at the 5”-OH of the pentose 
ring as we have shown for APH(3’)-IIIa [25]. Thus the 
,4PH(Z”) domain has 3’, 5”, 2” and 3”’ phosphoryl transfer 
capacity (Figure 5). 
Discussion 
Clinical aminoglycoside resistance in enterococci and 
staphylococci is the result of acquisition of modifying 
enzymes found on mobile genetic elements. Chief among 
these resistance proteins is AAC(6’)-APH(2”) [7]. This 
bifunctional enzyme is devastatingly effective at confer- 
ring resistance to virtually all aminoglycosides that incor- 
porate a Z-deoxystreptamine ring including the clinically 
important antibiotics gentamicin C, tobramycin, netilmicin 
and amikacin. The molecular basis for antibiotic resistance 
is the covalent modification of the drugs. Specifically, 
AAC(6’)-APH(2”) harbors both acetyl CoA-dependent 
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Products of AAC(G’)-APH(2”)-catalyzed 
acetylation and phosphorylation of 
aminoglycosides. 
IV-acetyltransferase and ATP-dependent O-phosphotrans- 
ferase activities [16]. These results suggest that the gene 
has arisen by a fusion of sac and a@ genes. Amino-acid 
sequence alignment revealed homology to other amino- 
glycoside N-acetyltransferases in the amino-terminal region 
and aminoglycoside kinases in the carboxy-terminal region, 
a designation that was confirmed by the construction of 
amino- and carboxy-terminal truncated enzymes [ 161. As 
a first step in delineating the molecular mechanism of 
this important enzyme, we required a good source of pure 
AAC(6’)-APH(2”). Several attempts were made to prepare 
an E. co/i overexpressing strain, but none of these proved 
fruitful (D.h/I.D. and G.D.W., unpublished observations), 
which led us to explore expression in B. szlbti/ir. Placement 
of the bifunctional gene under control of the constitutive 
UegZZ promoter gave dramatically better yields of enzyme 
when compared with any of the E. co/i strains and did 
not give any appreciable truncated product, which was a 
problem in E. COL. The reason for the improved yields in 
B. subtilis is unknown, but might reflect a superior ability 
of B. subs& to adjust to a foreign mRNA structure, which 
results in poor expression or ribosome stalling in E. co/i. 
A three-step purification protocol gave excellent yields of 
pure 57 kDa bifunctional enzyme with both AAC and APH 
activities. Steady-state kinetic analysis confirmed the broad 
substrate range of the enzyme, which was predicted by the 
in U&J aminoglycoside resistance profile. The AAC activ- 
ity shows remarkable substrate promiscuity. On the basis of 
these resistance profiles, the site of 1%acetylation was pre- 
dicted to be exclusively the primary amino group at C-6’ 
and this has recently been unambiguously established using 
NMR [ZO]. LJnlike other known AAC(6’) enzymes, AAC(6’)- 
APH(2”) confers resistance to fortimicin through Ar-acety- 
lation. All aminoglycosides with a free amino group at 
C6’ are excellent substrates with k,,,/K, of the order of 
lo5 M-l s-r. Aminoglycoside K, values vary from roughly 
l-26 @v4 and k,,, values from 0.2-3 s-r, but k,dK,, is largely 
invariant over the 15 6’-amino-aminoglycosides analyzed 
(maximum Ak,,dK,,, = 12.6). VI :e were surprised to find that 
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the h’-hydroxy aminoglycosides paromomycin and livido- 
mycin A are substrates for AAC(6’)-APH(2”) (Table 2). In 
comparison, these compounds are competitive inhibitors 
of kanamycin for E. faecizm AAC(6’)-Ii [Z?]. The acetyl 
group is readily removed under basic conditions suggest- 
ing 0-acetyltransfer is occurring and this activity was con- 
firmed by infrared analysis of acetyl-paromomycin. 
This unprecedented activity adds to the prodigious sub- 
strate range of the enzyme and serves as a cautionary note 
for future aminoglycoside development as amino or hydroxyl 
substitution is generally regarded as critical for biological 
activity. This is supported by recent NMR studies of paro- 
momycin bound to the A site of the E. co/i 16s rRNA, 
which have demonstrated at least one contact between the 
6’-OH to the phosphate group of Al493 [29]. Substitution 
of the AAC(6’) susceptible amino group at this position by 
a hydroxyl group will therefore not escape the acetyl-trans- 
fer activity of the AAC(6’)-APH(Z”) enzyme. 
The kinase activity of the AAC(6’)-,4PH(Z”) enzyme is 
highly tolerant of many different substitutions of the 6-amino 
pyranose ring (ring ‘4). The presence or absence of 
hydroxyl groups at C3’ and C4’, derivatization of CZ’ with 
OH or NH,, methylation at C6’ or unsaturation at C4’-CS’ 
have only minor effects on specificity. Similarly, substitu- 
tion of the Z-deoxystreptamine ring at C6 or at CS with 
hexose or pentoses respectively, is tolerated. A dramatic 
effect is observed, however, with substituents at Nl of the 
Z-deoxystreptamine ring. Amikacin (Nl-4-amino-Z-hydroxy 
butyryl-kanamycin A) shows a Z-fold increase in K, and 
a 2.5fold decrease in k,,, over kanamycin A, and butirosin 
(Nl-4-amino-Z-hydroxy butyryl-ribostamicin) has a M-fold 
higher K, than ribostamicin. Similarly, netilmicin (Nl- 
ethylsisomicin) has a threefold increase in K, and twofold 
decrease in k,,, over the parent compound sisomicin, and 
isepamicin (Nl-4-amino-Z-hydroxybutyryl-N3”-acetylgenta- 
micin B) has a fivefold increase in K, over gentamicin B. 
Thus Nl substitution is detrimental to the APH activity. 
Phosphorylation has been shown to occur at CZ” of the 
3-amino hexose ring (ring C) of 4,6-disubstituted Z-deoxy- 
streptamine aminoglycosides by heteronuclear NMR [ZO]. 
Consistent with this regiospecificity is the observation 
that compounds with a variety of substitutions at (25” (H, 
CH,OH) and C4” (H, axial OH, equatorial CH,) are toler- 
ated as is LV-methylation (gentamicins) or Ar-acetylation 
(isepamicin) of N3”. The 4,5-disubstituted Z-deoxystrep- 
tamine aminoglycosides, which have a pentose in ring C, 
are also efficiently phosphorylated. Aminoglycosides com- 
posed of two rings (neamine), three rings (ribostamycin and 
butirosin) and four rings (neomycin and paromomycin) are 
comparably phosphorylated, but the five-ring drug, livido- 
mycin, shows a 15-fold greater K,. Analysis of the products 
of neomycin phosphorylation revealed that the APH(2”) 
enzyme can also transfer a phosphate group to position 3’ 
of ring A and 3”’ of ring D. On the other hand. livido- 
mycin is phosphorylated on position 5” of the pentose 
ring. The K, difference for this compound compared with 
the other 4,5-disubstituted aminoglycosides might there- 
fore reflect either the influence of the E ring on substrate 
binding or a decrease in reactivity of the 5”-OH. Of course, 
these are not necessarily mutually exclusive. The impor- 
tant implication of these studies is that the APH(2”) activ- 
ity is relatively impervious to the structure of the amino- 
glycoside, and therefore this enzyme is a highly potent 
drug resistance determinant. 
Significance 
The remarkable potential for both N- and 0-acetyl 
transfer by the AAC(6’) activity coupled with the virtual 
indiscriminate capacity for phosphorylation of rings A, 
C and D of aminoglycosides by the APH(2”) domain of 
AAC(6’)-APH(2”) were unexpected and have sweep- 
ing implications. First, the broad specificities of both 
the acetyltransferase and kinase activities of AAC(6’)- 
APH(2”) give rise to an enzyme that has been exquis- 
itely evolved to counter virtually any 2-deoxystrep- 
tamine aminoglycoside antibiotic. Second, the distinct 
co-substrate requirements and mechanisms of the AAC 
and APH domains mean that the identification of a 
single inhibitor molecule that would have the capacity 
to attenuate AAC(6’)-APH(2”) activity and therefore 
potentiate aminoglycoside activity is remote. The broad 
specificity of both activities, however, implies significant 
capacity to recognize diverse structures. It should there- 
fore be possible to identify distinct inhibitory compounds 
for both domains that together could restore biological 
activity of clinically important aminoglycosides such as 
gentamicin C. 
Materials and methods 
Chemicals 
Isepamicin, sisomicin and netilimicin were gifts of G. Miller, Schering 
Plough Research Institute and gentamicin B and fortimicin were gifts of 
J. Davies, University of British Columbia. Neamine was the gift of Shahriar 
Mobashery, Wayne State University. All other aminoglycosides, 4,4’- 
dithiodipyridine and pyruvate kinase-lactate dehydrogenase mix were 
from Sigma. [yazP]-ATP was from DuPont-NEN. All restriction endonu- 
cleases and Vent DNA polymerase were from New England Biolabs. 
ATP and acetyl CoA were from Boehringer Manheim. AffiGel 15 was 
from BioRad, and all other chromatography resins were from Pharmacia. 
Overexpression of AAC(6?-APH(2’) in 13. subtilis 
The ax(#)-aph(2”) gene was amplified by PCR using Vent DNA 
polymerase from plasmid pSF815A [161 (gift of G. Eliopoulos, New 
England Deaconess Hospital, Boston, MA) using the DNA primers Pl 
(5’CCA GGT ACC CAT ATG AAT ATA GTT GAA AAT GAA) and P2 
(5’~CCA AAG C7T GGA TCC TCA ATC TTT ATA AGT CCT T-l-T) 
that incorporate unique Ndel and Hinolll restriction sites (denoted in 
italics), respectively. Plasmid pBF-9 was constructed by ligation of the 
1.5 kb bifunctional digested with Ndel and Hindlll with pKK223-3” 
digested with the same enzymes. Plasmid pKK223-3*’ was con- 
structed by destruction of an internal Ndel site in pKK223-3* [301. The 
construct pBF-9 places the bifunctional gene under control of the Tat 
promoter and contains the Shine-Delgarno sequence from gene IO of 
bacteriophage T7. Plasmid pBF-14 was constructed by ligation of the 
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1.5 kb Xbal to Ban&l fragment from pBF-9 with plasmid pRB374 [21] 
(gift from Reinhold Bruckner of Mikrobielle Genetik, Universitat Ttibin- 
gen, Tubingen, Germany). This placed the gene under the transcrip- 
tional control of the constitutive vegetative promoter, vegll, and the 
translational control of the ribosome-binding site from gene1 0 of bac- 
teriophage T7. This construct was used to transform the protease 
deficient strain B. subfilis 1 A752 (apr, bglTlbglS~~EV, eglS(A) 702, 
his, npr) (obtained from D.R. Zeigler, Bacillus Genetic Stock Center, 
Ohio State University, Columbus, OH) by electroporation using a Bio 
Rad Gene Pulser apparatus equipped with a pulse controller by minor 
modification of the method of Kusaoke et al. (31 I. 
Preparation of gentamicin C-agarose affinity column 
Affigel 15 (N-hydroxy succinimide activated agarose, BioRad) was 
washed with two volumes of isopropanol and six volumes of water. 
Gentamicin C complex (250 mg/ml) was then added in one volume of 
100 mM NaHCO, pH 8.3 and the slurry was gently rocked at 4°C for 
2 h and then incubated at room temperature for 2 h. The resin was fil- 
tered, placed in 1 M ethanolamine pH 8.3 to cap unreacted sites, and 
rocked at room temperature for 90 min. The suspension was filtered, 
washed with ten volumes of water, four volumes of 1.5 M (NHJSO,, 
followed by another ten volumes of water and resuspended in 50 mM 
HEPES pH 7.5, 1 mM EDTA and kept at 4°C. The resin was stored in 
5 mM NaN, when not in use. 
Purification of AAC(G’)-APH(2’) from B. subtilis 
lA752fpBF-14 
A 25 ml overnight culture of B. subtilis 1 A752/pBF-14 in Penassay broth 
(Difco antibiotic medium #3) served as inoculum for 10 I of Penassay 
broth supplemented with 200 pglml of gentamicin C. AAC(G’)-APH(2”) 
was purified from B. subtilis lA752/pBF-14. The culture was grown at 
37% until the end of logarithmic phase (OD,,, = 1.6). The cells were 
collected by centrifugation at 5000 x g for 10 min and resuspended in 
40 ml of lysis buffer (50 mM HEPES pH 7.5, 1 mM EDTA, 1 mM phenyl- 
methanesulfonyl fluoride and 0.1 mM dithiothreitol). Cell lysis was 
achieved by two consecutive passes through a French pressure cell at 
20,000 psi. The cell debris was removed by centrifugation at 10,000 x g 
for 20 min and the lysate was applied to a Q Sepharose FF anion 
exchange column (bed vol. 200 ml). The matrix was washed with several 
column volumes of buffer A (50 mM HEPES pH 7.5, 1 mM EDTA) and 
AAC(G’)-APH(2”) was eluted with a linear gradient with buffer B (50 mM 
HEPES pH 7.5, 1 mM EDTA and 1 M NaCI). Fractions were assayed for 
both APH and AAC enzymatic activities (described below). Active frac- 
tions eluted between 350 mM and 500 mM NaCI. These were pooled 
and concentrated to a final volume of 5 ml over an Amicon PM30 ultrafil- 
tration membrane. The concentrated sample was applied to a Sephadex 
GIOO gel filtration column (bed vol. 560ml) and eluted with buffer 
A + 200 mM NaCI. Active fractions were pooled, separated into two 
aliquots and dialyzed against buffer A. 
Both aliquots were separately loaded onto a gentamicin C-agarose 
affinity column (bed vol. 50 ml) and washed with three column volumes 
of buffer A. The bifunctional enzyme was eluted from the column with a 
linear gradient of buffer B at a flow rate of 0.5 ml/min. The fractions 
containing AAC(63-APH(2”) were pooled, concentrated over an Amicon 
PM30 membrane, and dialyzed against 25 mM HEPES pH 7.5. Pure 
bifunctional enzyme retained activity for at least 2 months at 4°C. 
Protein concentrations were determined using the Bradford method (321. 
Enzyme assays 
Routine assay for aminoglycoside phosphorylation during enzyme 
purification was performed using a phosphocellulose-binding assay 
as previously described [33] with kanamycin A and [y32P1-ATP. For 
more detailed analyses using purified enzymes, phosphorylation of 
aminoglycoside substrates by AAC(G’)-APH(2”) was monitored using 
a pyruvate kinasellactate dehydrogenase coupled assay system, 
which links the release of ADP to the oxidation of NADH to NAD+, 
and the resulting decrease in absorbance at 340 nm was monitored 
spectrophotometrically using a Cary 3E UV-visible spectrophotometer 
(231. Reactions contained 95OuI of assay buffer (50 mM HEPES 
pH 8.0, 10 mM MgCI,, 40 mM KCI, 0.5 mg/ml NADH, 2.5 mM phos- 
phoenolpyruvate and 1 mM ATP). A volume of 25 ul of aminoglycoside 
solution was added and the mixtures were preincubated at 36°C for 
5 min. The reactions were initiated by the addition of 25 pl of enzyme 
solution (typically 0.8 mg/ml stock solution). Fractions throughout the 
enzyme purification were assayed with 100 uM kanamycin A and were 
corrected for the presence of contaminating ATPases when required 
by a control reaction lacking the aminoglycoside substrate. 
All substrates for the kinetic assays were titrated using the coupled 
assay. Initial rates were obtained directly from the progress curves and 
then analyzed without external weighting by nonlinear least squares fit 
to equation 1 or equation 2 for reactions where substrate inhibition was 
observed, using the Grafit 3.0 software (341. Kinetic constants are 
reported + the standard error obtained from the fit of the data. 
v = V,,S/(K, + S) 
v = V,,S/(K, + S + S2/K,) (2) 
The acetylation of aminoglycoside substrates was monitored by cou- 
pling the acetylation of the aminoglycoside to the cleavage of 4,4’- 
dithiodipyridine which gives an increase in absorbance monitored at 
324 nm (E, 19,800 M-‘cm-l) 1351. Reactions contained 800 pl of 
assay buffer (50 mM HEPES pH 7.0, 1 mM EDTA, 2 mM 4,4’-dithio- 
dipyridine, 80 uM acetyl CoA and 25 pl of aminoglycoside solution). 
The solutions were preincubated at 37°C for 5 min and then the reac- 
tions were initiated by the addition of 25 ul of enzyme solution 
(0.8 ug/ml). Initial rates were analyzed as described above. 
Determination of regiospecificity of phosphoryl transfer by NMR 
All spectra were recorded on a Bruker Avance DRX-500 NMR spec- 
trometer. Proton spectra were acquired at 500.13 MHz using a 5 mm 
broadband inverse probe with triple axis gradient capability. Spectra 
were obtained in 120 scans in 32K data points over a 3.894 kHz spec- 
tral width (4.207 s acquisition time). Sample temperature was main- 
tained at 30°C by a Bruker Eurotherm variable temperature unit. The 
free induction decay (FID) was processed using Gaussian multiplica- 
tion (line broadening: -1.5 Hz, Gaussian broadening: 0.2). The FID 
was also zero-filled to 64K before Fourier transformation. 
Proton COSY two-dimensional NMR spectra were recorded in the 
absolute value mode using the pulse sequence 90”-t,-45’- acq and 
included pulsed field gradients for coherence selection. The data were 
acquired in 48 scans for each of the 256 FlDs that contained 2K data 
points in the F2 dimension over a 3.205 kHz spectral width. The ‘H 90 
pulse width was 6.6 us. A 1 .O s relaxation delay was used between 
acquisitions. Zero-filling in the Fl dimension produced a 1 K x 1 K data 
matrix with a digital resolution of 3.130 Hz/point in both dimensions. 
During two-dimensional Fourier transformation a sine-bell squared 
window function was applied to both dimensions. The transformed 
data were then symmetrized. 
Phosphorus-31 NMR spectra were recorded at 202.456 MHz using 
the 5 mm broadband inverse probe with triple axis gradient capability. 
The spectra were acquired over a 48.544 kHz spectral width in 32K 
data points (0.338 s acquisition time). The 31P pulse width was 3.0 us 
(30 flip angle). A relaxation delay of 0.5 s was used. The FID was 
processed using exponential multiplication (line broadening: 4.0 Hz) 
and zero-filled to 64K before Fourier transformation. 
The transverse ROESY two-dimensional spectra were acquired in the 
phase sensitive mode. The data were acquired in 96 scans for each 
of the 128 FlDs that contained 2K data points in the F2 dimension 
over a 3.931 kHz spectral width. The ‘H 90 pulse width was 6.6 us 
while the 90 pulse width for the spin locking pulse was 104.0 us. A 
1 .O s relaxation delay was used between acquisitions. A mixing time 
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of 800.0 ms was used. Linear prediction to 256 data points followed 
by zero-filling in the Fl dimension produced a 1Kx 1K data matrix 
with a digital resolution of 3.130 Hz/point in both dimensions. During 
the real two-dimensional Fourier transformation a sine-bell squared 
window function shifted by n/2 was applied to both dimensions. The 
transformed data were not symmetrized. The ROESY two-dimen- 
sional spectrum was plotted displaying negative contours only. 
Selective one-dimensional TOCSY IH NMR spectra were recorded 
over a 4.006 KHz spectral width in 32K data points (4.089 s acquisi- 
tion time). Gaussian shaped pulses were defined by 256 data points 
with the pulse being truncated at 1% of the maximum pulse amplitude. 
The 90 Gaussian pulse width was 25.5 ps. This pulse was followed by 
a 40 us fixed delay and then by the standard TOCSY MLEV-17 spin 
lock pulse sequence. The 90 spin lock pulse width was 27.0 us. A 
1 .O s relaxation delay was used. Spin lock periods of either 40.0 or 
120.0 ms were used and this was followed by a z-filter which con- 
tained 5 variable delay times ranging from 4.0 to 18.0 ms. The transmit- 
ter offset was adjusted to the frequency of the r H being selectively 
excited. Thirty-two scans were acquired for each of the delays in the z- 
filter resulting in a total of 180 scans. The FID was processed using 
Gaussian multiplication (line broadening: -1.5 Hz; Gaussian broaden- 
ing: 0.2) and was zero-filled to 64K before Fourier transformation. 
The compounds used in this study were dissolved in 99.996% D,O 
(Isotec, Inc.) to a concentration of approximately 3.0 mg/ml for neomycin- 
bisphosphate and 15.0 mglml for neomycin, Chemical shifts are reported 
in ppm relative to TMS using the HDO signals at 4.60 ppm as internal 
reference for the rH NMR spectra Phosphorus-31 NMR spectra were 
referenced using external 85% phosphoric acid in D,O. 
Base hydrolysis of acetylated aminoglycosides 
Reactions contained 100 pM aminoglycoside, 36.4 pM [r4C]-acetyl 
CoA (1.2 x 1 O5 cpm/nmol), AAC(APH(“) (2.6 pmol) and HEPES 
HCI buffer, pH 7.5 in a final volume of 10 ~1. Following completion of 
the acetyl transfer reaction, 10 ul of 80 mM NaOH was added and the 
reaction mixtures incubated at 80°C (final pH 11-l 2). Samples were 
neutralized with the addition of 10 ul of 1 M HEPES pH 7.5 and ana- 
lyzed by application of the solution on Whatman P-81 phosphocellu- 
lose paper. The papers were washed three times in water, dried, and 
the amount of radioactivity bound determined by scintillation counting. 
Thin layer chromatography, purification and infrared 
spectroscopy 
0-acetylated paromomycin was produced by incubating 5 mg of the 
aminoglycoside (150 PM), 150 FM acetyl Coenzyme A, 300 nM 
AAC(G’)-APH(2”) in 50 ml of 50 mM HEPES pH 7.5 for 4 h. The 
modified aminoglycoside product was partially purified by batch 
anion exchange chromatography on AG50W-X8 resin with a 1% 
NH,OH step gradient. The eluted product was concentrated by 
lyophilization and resuspended in 1 ml of water. Samples were then 
separated on Whatman PLK-5 glass-backed silica plates using a 5:2 
methanol:ammonium hydroxide mobile phase. The R, of the product 
was 0.23 whereas that of paromomycin was 0.35. Silica was 
scraped off the plate and the acetylated aminoglycoside was 
extracted with 15 ml of methanol under mildly acidic conditions. 
Samples were neutralized by the dropwise addition of NaOH fol- 
lowed by lyophilization. The dried product was ground into a KBr 
pellet and analyzed by infrared spectroscopy using a BioRad FTS-40 
Fourier Transform Infrared Spectrometer. 
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